Merck KGaA (OTCMKTS:MKGAF – Get Free Report)’s share price reached a new 52-week high on Wednesday . The company traded as high as $193.63 and last traded at $193.63, with a volume of 251 shares changing hands. The stock had previously closed at $183.00.
Merck KGaA Price Performance
The firm has a market capitalization of $24.09 billion, a PE ratio of 27.31 and a beta of 0.98. The business’s 50 day moving average is $171.38 and its two-hundred day moving average is $167.09. The company has a debt-to-equity ratio of 0.35, a quick ratio of 0.89 and a current ratio of 1.42.
Merck KGaA (OTCMKTS:MKGAF – Get Free Report) last announced its quarterly earnings results on Wednesday, May 15th. The company reported $1.74 earnings per share for the quarter, missing the consensus estimate of $1.92 by ($0.18). The company had revenue of $5.56 billion during the quarter. Merck KGaA had a net margin of 13.09% and a return on equity of 11.69%. Equities research analysts anticipate that Merck KGaA will post 9.73 earnings per share for the current fiscal year.
About Merck KGaA
Merck KGaA operates as a science and technology company in Germany. It operates through Life Science, Healthcare, and Electronics segments. The company's Life Science segment offers tools, chemicals, and equipment for academic labs, biotech, and pharmaceutical manufacturers, as well as industrial sector.
Featured Articles
- Five stocks we like better than Merck KGaA
- What is the NASDAQ Stock Exchange?
- Top 5 High-Performance Cryptocurrency ETFs to Watch
- How Investors Can Identify and Successfully Trade Gap-Down Stocks
- 3 Stocks That Plummeted After the Post-Fed Speech Crash
- Stock Splits, Do They Really Impact Investors?
- Adobe Stock: It’s Not Too Late To Buy The Dip
Receive News & Ratings for Merck KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merck KGaA and related companies with MarketBeat.com's FREE daily email newsletter.
